Key Therap Company Profile
What is the competitive landscape for KEY THERAP
KEY THERAP has four approved drugs.
There is one US patent protecting KEY THERAP drugs.
Summary for Key Therap
| US Patents: | 1 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Key Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Therap | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 206615-001 | Aug 4, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | DISCN | Yes | No | 7,304,078 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Key Therap | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 088237-001 | Apr 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785-001 | Nov 26, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Key Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,235,567 | ⤷ Start Trial |
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,713,999 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Key Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 535880 | ⤷ Start Trial |
| Russian Federation | 2293735 | ⤷ Start Trial |
| South Africa | 200210099 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0196330 | ⤷ Start Trial |
| Taiwan | 200526643 | ⤷ Start Trial |
| Canada | 2545060 | ⤷ Start Trial |
| Taiwan | I295291 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Key Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1495018 | 2015C/037 | Belgium | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR, OU SON SEL OU SOLVAT PHARMACOLOGIQUEMENT ADMISSIBLE; AUTHORISATION NUMBER AND DATE: EU/1/14/976/001 |
| 1495018 | 300746 | Netherlands | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT, IN HET BIJZONDER VORAPAXARSULFAAT; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121 |
| 1495018 | PA2015027,C1495018 | Lithuania | ⤷ Start Trial | PRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119 |
| 1495018 | 15C0047 | France | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR,OU L'UN DE SES SELS OU SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121 |
| 1495018 | S1500036 | Hungary | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119 |
| 1495018 | C300746 | Netherlands | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119 |
| 1495018 | C 2015 030 | Romania | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR SAU O SARE ACCEPTABILA FARMACEUTIC SAU SOLVATAL ACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/14/976/001, EU/1/14/976/002, EU/1/14/976/003, EU/1/14/976/004, EU/1/14/976/005, EU/1/14/976/006; DATE OF NATIONAL AUTHORISATION: 20150119; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/976/001, EU/1/14/976/002, EU/1/14/976/003, EU/1/14/976/004, EU/1/14/976/005, EU/1/14/976/006; DATE OF FIRST AUTHORISATION IN EEA: 20150119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
